Pegasus Biologics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Pegasus Biologics's estimated annual revenue is currently $6.8M per year.(i)
  • Pegasus Biologics's estimated revenue per employee is $251,000

Employee Data

  • Pegasus Biologics has 27 Employees.(i)
  • Pegasus Biologics grew their employee count by 0% last year.

Pegasus Biologics's People

NameTitleEmail/Phone
1
Cofounder & CFOReveal Email/Phone
2
Co-Founder, Chief Operating OfficerReveal Email/Phone
3
Senior ScientistReveal Email/Phone
4
Associate ScientistReveal Email/Phone
5
Senior Scientist-Vaccine Technology DevelopmentReveal Email/Phone
6
Principal ScientistReveal Email/Phone
7
Associate ScientistReveal Email/Phone
8
Associate ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Pegasus Biologics?

Pegasus Biologics is an emerging growth regenerative medicine company focused on manufacturing and commercializing advanced bio-surgical solutions for soft tissue repair and regeneration. Currently selling in the United States and abroad through a highly trained sales organization, Pegasus Biologics is becoming recognized as a global leader in this market segment. Current product applications range from the repair, reinforcement, and reconstruction of soft tissue, to limb preservation and advanced wound management.

keywords:N/A

N/A

Total Funding

27

Number of Employees

$6.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pegasus Biologics News

2022-04-17 - Studies at UF Veterinary College Aim to Advance Horse Health

... the $3-million GI Pegasus World Cup at Gulfstream Park, ... The use of novel biologic agents to treat allergies in horses would avoid...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M27-13%N/A
#2
$2.7M27N/AN/A
#3
$2.7M27N/AN/A
#4
$1.9M278%$3M
#5
$2.7M27N/AN/A